why choose us

First received: June 15, 2023

Clinical Trial: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Study Status: Completed

Recruit Status: RECRUITING

Condition: Single Ventricle Heart Disease

Study Type: INTERVENTIONAL


Official Title: Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL-2)

Brief Summary: This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of adolescent who have had the Fontan procedure.

Read more